BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25778910)

  • 1. Meta-analyses: what is heterogeneity?
    Sedgwick P
    BMJ; 2015 Mar; 350():h1435. PubMed ID: 25778910
    [No Abstract]   [Full Text] [Related]  

  • 2. Meta-analysis: statistical alchemy for the 21st century.
    Feinstein AR
    J Clin Epidemiol; 1995 Jan; 48(1):71-9. PubMed ID: 7853050
    [No Abstract]   [Full Text] [Related]  

  • 3. Exploring heterogeneity in meta-analyses: needs, resources and challenges.
    Xu H; Platt RW; Luo ZC; Wei S; Fraser WD
    Paediatr Perinat Epidemiol; 2008 Jan; 22 Suppl 1():18-28. PubMed ID: 18237348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mega-trials vs. meta-analysis: precision vs. heterogeneity?
    Shrier I; Platt RW; Steele RJ
    Contemp Clin Trials; 2007 May; 28(3):324-8. PubMed ID: 17188025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research.
    Sterne JA; Jüni P; Schulz KF; Altman DG; Bartlett C; Egger M
    Stat Med; 2002 Jun; 21(11):1513-24. PubMed ID: 12111917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical and updated guidelines on performing meta-analyses of non-randomized studies in interventional cardiology.
    Navarese EP; Koziński M; Pafundi T; Andreotti F; Buffon A; Servi SD; Kubica J
    Cardiol J; 2011; 18(1):3-7. PubMed ID: 21305479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Practice of systematic reviews. VII. Pooling of results from observational studies].
    Zeegers MP; Heisterkamp SH; Kostense PJ; van der Windt DA; Scholten RJ
    Ned Tijdschr Geneeskd; 2000 Jul; 144(29):1393-7. PubMed ID: 10923147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistics for quantifying heterogeneity in univariate and bivariate meta-analyses of binary data: the case of meta-analyses of diagnostic accuracy.
    Zhou Y; Dendukuri N
    Stat Med; 2014 Jul; 33(16):2701-17. PubMed ID: 24903142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpretation of tests of heterogeneity and bias in meta-analysis.
    Ioannidis JP
    J Eval Clin Pract; 2008 Oct; 14(5):951-7. PubMed ID: 19018930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of excess statistical significance in meta-analyses of 98 biomarker associations with cancer risk.
    Tsilidis KK; Papatheodorou SI; Evangelou E; Ioannidis JP
    J Natl Cancer Inst; 2012 Dec; 104(24):1867-78. PubMed ID: 23090067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data discrepancies in meta-analyses that use standarized mean differences.
    McGuire H; Edmonds M; Price J
    JAMA; 2007 Nov; 298(19):2261-2; author reply 2262-3. PubMed ID: 18029827
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibiotic treatment of bacterial vaginosis in pregnancy: multiple meta-analyses and dilemmas in interpretation.
    Varma R; Gupta JK
    Eur J Obstet Gynecol Reprod Biol; 2006 Jan; 124(1):10-4. PubMed ID: 16129546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis in occupational epidemiology: a review of practice.
    McElvenny DM; Armstrong BG; Järup L; Higgins JP
    Occup Med (Lond); 2004 Aug; 54(5):336-44. PubMed ID: 15289591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dependent effect sizes in meta-analysis: incorporating the degree of interdependence.
    Cheung SF; Chan DK
    J Appl Psychol; 2004 Oct; 89(5):780-91. PubMed ID: 15506860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal activated clotting time during percutaneous coronary intervention.
    Hanratty CG; Ward M
    Circulation; 2001 Oct; 104(15):E83-4. PubMed ID: 11591634
    [No Abstract]   [Full Text] [Related]  

  • 16. Can meta-analyses be trusted?
    Thompson SG; Pocock SJ
    Lancet; 1991 Nov; 338(8775):1127-30. PubMed ID: 1682553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials.
    Baujat B; Mahé C; Pignon JP; Hill C
    Stat Med; 2002 Sep; 21(18):2641-52. PubMed ID: 12228882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robustness assessments are needed to reduce bias in meta-analyses that include zero-event randomized trials.
    Keus F; Wetterslev J; Gluud C; Gooszen HG; van Laarhoven CJ
    Am J Gastroenterol; 2009 Mar; 104(3):546-51. PubMed ID: 19262513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deriving treatment recommendations from evidence within randomized trials. The role and limitation of meta-analysis.
    Freemantle N; Mason J; Eccles M
    Int J Technol Assess Health Care; 1999; 15(2):304-15. PubMed ID: 10507190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing heterogeneity in meta-analysis: Q statistic or I2 index?
    Huedo-Medina TB; Sánchez-Meca J; Marín-Martínez F; Botella J
    Psychol Methods; 2006 Jun; 11(2):193-206. PubMed ID: 16784338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.